We are not seeing an explosion of new research
Each treatment plan is customized and overseen by a licensed clinician to ensure appropriate dosing and monitoring
This article is designed to answer some of the most common questions people ask about semaglutide, particularly around its effects on urination
2 Schematic of plasma glucagon-like peptide 1 (GLP-1) analog levels and plasma glucose levels with short- versus long (or prolonged)-acting analogs
2008 Therrien G, Rose C, Butterworth J, Butterworth RF: Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat
Patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, uncontrolled diabetes, or severe renal impairment should not use GLP-1 medications